Burke, 1961, Effective period of preventive antibiotic action in experimental incisions and dermal lesions, Surgery, 50, 161
Kernbaum, 1982, Antibiothérapie prophylactique en chirurgie, Nouv Presse Méd, 11, 43
Firor, 1967, Infection following open-heart surgery with special reference to the role of prophylactic antibiotics, J Thorac Cardiovasc Surg, 53, 371, 10.1016/S0022-5223(19)43201-7
Akl, 1980, Serum cefazolin levels during cardiopulmonary bypass, Ann Thorac Surg, 29, 109, 10.1016/S0003-4975(10)61646-3
Austin, 1977, Cephalosporin prophylaxis and valve replacement, Ann Thorac Surg, 23, 333, 10.1016/S0003-4975(10)64136-7
Eigel, 1978, Assays of cephalosporin antibiotics administered prophylactically in open heart surgery, Infection, 6, 23, 10.1007/BF01641087
Kini, 1978, Doubleblind comparison of cefazolin and cephalothin in open-heart surgery, J Thorac Cardiovasc Surg, 76, 506, 10.1016/S0022-5223(19)41080-5
Sande, 1985, Chemotherapy of microbial diseases, 1066
Bernstein, 1986, Relative efficacy and toxicity of netilmicin and tobramycin in oncology patients, Arch Intern Med, 146, 3329, 10.1001/archinte.1986.00360240043008
Parker, 1980, Comparative nephrotoxicity of high-dose netilmicin and tobramycin in rats, Antimicrob Agents Chemother, 18, 346, 10.1128/AAC.18.2.346
Szot, 1980, Comparative toxicity of netilmicin and tobramycin in dogs, Toxicol Appl Pharmacol, 55, 169, 10.1016/0041-008X(80)90233-1
Stanbridge, 1984, Netilmicin prophylaxis in open-heart surgery, J Antimicrob Chemother, 13, 59, 10.1093/jac/13.suppl_A.59
Jolley, 1981, Fluorescence immunoassay. I. Monitoring aminoglycoside antibiotics in serum and plasma, Clin Chem, 27, 1190, 10.1093/clinchem/27.7.1190
Witebsky, 1983, Evaluation of four gentamicin and tobramycin assay procedures for clinical laboratories, J Clin Microbiol, 18, 890, 10.1128/JCM.18.4.890-894.1983
Bennet, 1966, Simplified method for antibiotic assay of clinical specimen, Applied Microbiology, 14, 170, 10.1128/AEM.14.2.170-177.1966
Metzler, 1974, A package of computer programs for pharmacokinetic modeling, Biometrics, 30, 562
Benet, 1979, Non-compartmental determination of the steady-state volume of distribution, J Pharm Sci, 68, 1071, 10.1002/jps.2600680845
Knothe, 1974, Die mikrobiologische Aktivität von Cephalotin, Cephalexin, Cephacetril, Ceptiradin, Cefazolin and Cefamandol
Miller, 1980, Effect of cardiopulmonary bypass on cefazolin disposition, Clin Pharmacol Ther, 27, 550, 10.1038/clpt.1980.78
Goodman-Gilman, 1985, The Pharmacological Basis of Therapeutics, 1674
Smith, 1987, Microvascular permeability after cardiopulmonary bypass. An experimental study, Thorac Cardiovasc Surg, 94, 225, 10.1016/S0022-5223(19)36285-3
Bravery, 1980, Antimikrobielle Aktivität von Gentamicin, Sisomicin, Tobramycin, Netilmicin and Amikacin and deren Resistenzmuster, Arzneim Forsch Drug Res, 30, 491
Briedis, 1976, Comparative activity of netilmicin, gentamicin, amikacin and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae, Antimicrob Agent Chemother, 50, 592, 10.1128/AAC.10.4.592
Fu, 1976, In vitro study of netilmicin compared with other aminoglycosides, Antimicrob Agents Chemother, 10, 526, 10.1128/AAC.10.3.526
Just, 1983, Penetration of netilmicin into heart valves, subcutaneous and muscular tissue of patients undergoing heart surgery, Clin Cardiol, 6, 217, 10.1002/clc.4960060505
Koren, 1985, Influence of hypothermia on the pharmacokinetics of gentamicin and theophylline in piglets, Crit Care Med, 13, 844, 10.1097/00003246-198510000-00014
Jahre, 1978, Kinetics of netilmicin and gentamicin, Clin Pharmacol Ther, 23, 591, 10.1002/cpt1978235591
Klamerus, 1988, Effect of cardiopulmonary bypass on vancomycin and netilmicin disposition, Antimicrob Agents Chemother, 32, 631, 10.1128/AAC.32.5.631